Subsequent Events (Details) - Subsequent Event [Member] - USD ($) |
Nov. 01, 2022 |
Oct. 31, 2022 |
Oct. 24, 2022 |
Dec. 15, 2022 |
---|---|---|---|---|
Subsequent Events (Details) [Line Items] | ||||
Term agreement, description | Pursuant to this agreement, the term of the contract is for one year, beginning on January 1, 2023; the financial terms of the contract are a commitment of £125,000 per quarter, with the first payment due in April 2023. | |||
Reimbursement claim | $ 129,483 | |||
Pre-funded warrants, description | On November 1, 2022, the remainder, or 1,085,000, of the July 2022 Pre-Funded Warrants were exercised for a value of $109; there are no remaining outstanding July 2022 Pre-Funded Warrants. | |||
Reverse stock split share par value | $ 0.0001 | |||
Pre-Funded Warrants [Member] | ||||
Subsequent Events (Details) [Line Items] | ||||
Excess of ownership, percentage | 4.00% | |||
Director [Member] | ||||
Subsequent Events (Details) [Line Items] | ||||
Common stock par value | $ 0.0001 |
X | ||||||||||
- Definition Excess of ownership percentage. No definition available.
|
X | ||||||||||
- Definition Pre funded warrants, Description. No definition available.
|
X | ||||||||||
- Definition The amount of reimbursement claim. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Face amount per share of no-par value common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Par value per share of mandatory redeemable financial instrument classified as liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Information about borrowings which initially required repayment in less than twelve months (or normal operating cycle, if longer) after its issuance and that does not otherwise qualify as long-term debt. It typically is comprised of borrowings under letters of credit, lines of credit, commercial paper, and notes payable of short duration. Disclosures include amounts of borrowings under each arrangement, description of underlying arrangements, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements such as the effects of refinancings and noncompliance with debt covenants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|